Oral Dosage Forms Market Trends and Outsourcing Dynamics

Report Overview

Today, according to IMS Health, nine of the top ten drugs based on monthly prescription volume are oral solid doses and the top selling drug by sales figures is also an oral solid dose. Both the market dominance and long history of oral dosage forms make this category of drug product a strong candidate for outsourced manufacturing.

This report provides an overview of the current market dynamics in the oral dosage forms contract manufacturing space as well as an outlook of what our survey respondents—all oral dosage outsourcing decision-makers at sponsor organizations—predict the marketplace will look like in 2020. Key statistics include the volume of oral solid dose manufacturing projects, the proportion of these studies that are outsourced, and the average dollar value of these studies.

What you will learn:

• Oral Dosage Outsourcing Penetration
• Oral Dosage Forms—Anticipated Areas of Growth
• Service Provider Perception and Selection
• Motivations behind Use or Avoidance of Emerging Market Providers
• Reasons Service Providers Lose Bids
• Oral Dosage Project Volume, and Number of CMOs used
• Oral Dosage Forms Life Cycle Management
• Oral Dosage Drug Product Technologies with Increasing Demand

Methodology:

ISR surveyed 105 respondents who:

• Work for a pharmaceutical or biotech company
• Work in manufacturing—commercial or clinical and commercial responsibilities—API sourcing/management, outsourcing/procurement, quality assurance, regulatory, supply chain, or executive management
• Have responsibility for outsourced drug product manufacturing of oral dosage forms within the past 18 months
• Play a role in gathering information about service providers, selecting service providers, and/or managing service provider activities